Cedelizumab

Cedelizumab is a monoclonal antibody acting on the immune system.[1] Possible indications include the prevention of organ transplant rejections and the treatment of autoimmune diseases.[2]

Cedelizumab
Monoclonal antibody
TypeWhole antibody
SourceHumanized (from mouse)
TargetCD4
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
KEGG
 NY (what is this?)  (verify)

References

  1. WHO Drug Information
  2. The NDA pipeline. F-D-C Development Corporation. 2001.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.